USANA Health Sciences (NYSE:USNA) Price Target Raised to $38.00

USANA Health Sciences (NYSE:USNA) had its target price increased by stock analysts at DA Davidson from $35.00 to $38.00 in a report released on Thursday,Benzinga reports. The firm presently has a “neutral” rating on the stock. DA Davidson’s price target points to a potential upside of 5.06% from the company’s previous close.

Separately, StockNews.com upgraded shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a report on Saturday, December 28th.

USANA Health Sciences Stock Performance

USANA Health Sciences stock opened at $36.17 on Thursday. The firm has a 50 day moving average price of $37.86 and a two-hundred day moving average price of $39.59. USANA Health Sciences has a 52-week low of $31.44 and a 52-week high of $52.75. The firm has a market cap of $689.40 million, a price-to-earnings ratio of 12.78, a PEG ratio of 1.25 and a beta of 0.89.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings data on Tuesday, October 22nd. The company reported $0.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.49 by $0.07. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The company had revenue of $200.22 million for the quarter, compared to the consensus estimate of $208.45 million. During the same period in the previous year, the business earned $0.59 EPS. As a group, equities research analysts predict that USANA Health Sciences will post 2.45 EPS for the current fiscal year.

Insider Buying and Selling

In other USANA Health Sciences news, Director Gilbert A. Fuller sold 675 shares of the firm’s stock in a transaction on Monday, November 4th. The shares were sold at an average price of $37.71, for a total value of $25,454.25. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.33% of the stock is owned by company insiders.

Institutional Investors Weigh In On USANA Health Sciences

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Pzena Investment Management LLC grew its holdings in USANA Health Sciences by 7.5% during the third quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company’s stock worth $39,801,000 after buying an additional 72,977 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in USANA Health Sciences by 0.6% during the 2nd quarter. Dimensional Fund Advisors LP now owns 683,158 shares of the company’s stock worth $30,907,000 after acquiring an additional 3,889 shares during the last quarter. Pacer Advisors Inc. boosted its holdings in USANA Health Sciences by 16.5% during the 3rd quarter. Pacer Advisors Inc. now owns 544,256 shares of the company’s stock worth $20,638,000 after acquiring an additional 76,904 shares during the last quarter. State Street Corp grew its stake in shares of USANA Health Sciences by 0.6% in the 3rd quarter. State Street Corp now owns 435,164 shares of the company’s stock worth $16,501,000 after acquiring an additional 2,782 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of USANA Health Sciences by 4.5% during the third quarter. Geode Capital Management LLC now owns 297,120 shares of the company’s stock valued at $11,269,000 after purchasing an additional 12,898 shares in the last quarter. Institutional investors and hedge funds own 54.25% of the company’s stock.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.